id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0150-0015,FDA,FDA-2008-D-0150,"Guidance for Industry; Availability: Hypertension Indication, Drug Labeling for Cardiovascular Outcome Claims",Notice,NAD-Notice of Availability of Data,2011-03-15T04:00:00Z,2011,3,2011-03-15T04:00:00Z,2011-05-17T03:59:59Z,2011-03-16T12:35:04Z,2011-05945,0,0,0900006480c07f51
FDA-2008-D-0150-0016,FDA,FDA-2008-D-0150,"Guidance for Industry; Hypertension Indication, Drug Labeling for Cardiovascular Outcome Claims",Other,GDL-Guidance (Supporting and Related Materials),2011-03-15T04:00:00Z,2011,3,2011-03-15T04:00:00Z,,2011-03-16T12:39:53Z,,0,0,0900006480c081c0